End-of-day quote
Colombo S.E.
23:00:00 07/05/2024 BST
|
5-day change
|
1st Jan Change
|
89
LKR
|
+15.28%
|
|
+4.71%
|
+29.74%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,000
|
929.2
|
628.3
|
1,208
|
1,175
|
1,217
|
Enterprise Value (EV)
1 |
247.7
|
-314.2
|
-521.5
|
-711
|
-683
|
-920.3
|
P/E ratio
|
3.86
x
|
7.78
x
|
2.74
x
|
51.3
x
|
10.5
x
|
6.85
x
|
Yield
|
3.15%
|
3.39%
|
5%
|
1.3%
|
2.67%
|
3.23%
|
Capitalization / Revenue
|
1.38
x
|
2.02
x
|
1.59
x
|
2.74
x
|
1.84
x
|
1.14
x
|
EV / Revenue
|
0.34
x
|
-0.68
x
|
-1.32
x
|
-1.61
x
|
-1.07
x
|
-0.87
x
|
EV / EBITDA
|
-2.25
x
|
-24.9
x
|
60.7
x
|
-15.4
x
|
-6.48
x
|
-3.4
x
|
EV / FCF
|
-0.75
x
|
-0.49
x
|
-71.6
x
|
-9.05
x
|
5.61
x
|
-3.04
x
|
FCF Yield
|
-133%
|
-204%
|
-1.4%
|
-11%
|
17.8%
|
-32.9%
|
Price to Book
|
0.47
x
|
0.47
x
|
0.35
x
|
0.49
x
|
0.46
x
|
0.46
x
|
Nbr of stocks (in thousands)
|
15,750
|
15,750
|
15,707
|
15,707
|
15,707
|
15,707
|
Reference price
2 |
63.50
|
59.00
|
40.00
|
76.90
|
74.80
|
77.50
|
Announcement Date
|
01/06/18
|
03/06/19
|
04/09/20
|
03/06/21
|
03/06/22
|
05/06/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
723.6
|
460
|
395.8
|
441.4
|
639.7
|
1,064
|
EBITDA
1 |
-110.2
|
12.61
|
-8.587
|
46.28
|
105.4
|
270.7
|
EBIT
1 |
-113.8
|
11.69
|
-8.851
|
46.26
|
105.1
|
270
|
Operating Margin
|
-15.73%
|
2.54%
|
-2.24%
|
10.48%
|
16.43%
|
25.39%
|
Earnings before Tax (EBT)
1 |
379
|
101.8
|
237.3
|
34.62
|
127.8
|
255.6
|
Net income
1 |
259.1
|
119.5
|
229.5
|
23.53
|
111.8
|
177.6
|
Net margin
|
35.81%
|
25.97%
|
57.97%
|
5.33%
|
17.48%
|
16.7%
|
EPS
2 |
16.45
|
7.585
|
14.61
|
1.498
|
7.119
|
11.31
|
Free Cash Flow
1 |
-330.4
|
641.1
|
7.28
|
78.52
|
-121.7
|
302.4
|
FCF margin
|
-45.66%
|
139.36%
|
1.84%
|
17.79%
|
-19.03%
|
28.43%
|
FCF Conversion (EBITDA)
|
-
|
5,083.31%
|
-
|
169.66%
|
-
|
111.72%
|
FCF Conversion (Net income)
|
-
|
536.62%
|
3.17%
|
333.75%
|
-
|
170.3%
|
Dividend per Share
2 |
2.000
|
2.000
|
2.000
|
1.000
|
2.000
|
2.500
|
Announcement Date
|
01/06/18
|
03/06/19
|
04/09/20
|
03/06/21
|
03/06/22
|
05/06/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
752
|
1,243
|
1,150
|
1,919
|
1,858
|
2,138
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-330
|
641
|
7.28
|
78.5
|
-122
|
302
|
ROE (net income / shareholders' equity)
|
19%
|
4.56%
|
12.3%
|
0.91%
|
3.92%
|
6.54%
|
ROA (Net income/ Total Assets)
|
-3.27%
|
0.34%
|
-0.29%
|
1.32%
|
2.5%
|
6.11%
|
Assets
1 |
-7,935
|
34,951
|
-80,286
|
1,783
|
4,469
|
2,906
|
Book Value Per Share
2 |
135.0
|
124.0
|
113.0
|
156.0
|
161.0
|
170.0
|
Cash Flow per Share
2 |
22.60
|
26.50
|
30.00
|
1.160
|
1.090
|
8.810
|
Capex
1 |
3.02
|
1.27
|
-
|
0.04
|
0.89
|
15.1
|
Capex / Sales
|
0.42%
|
0.28%
|
-
|
0.01%
|
0.14%
|
1.42%
|
Announcement Date
|
01/06/18
|
03/06/19
|
04/09/20
|
03/06/21
|
03/06/22
|
05/06/23
|
|
1st Jan change
|
Capi.
|
---|
| +29.74% | 4.68M | | -2.06% | 73.82B | | +2.16% | 47.49B | | +1.85% | 32.7B | | +4.50% | 17.15B | | -6.78% | 11.92B | | +12.29% | 11.85B | | +0.65% | 10.66B | | +9.00% | 9.76B | | -7.59% | 8.31B |
Diversified Chemicals
|